Justin Briggs

About Justin Briggs

Justin Briggs is an entrepreneur, investor, and scientist who lives to build companies making significant impact. A native Tulsan, Justin supports the ecosystem of founders and investors in Tulsa, Oklahoma, and the region. Justin also serves as Biologist and Operating Partner at Prime Movers Lab, a leading investor of breakthrough science. PML invests in scientific founders leading companies with the potential to impact billions of lives. Boards: Justin serves as a member of the board of directors at Bioeutectics, ByBug, Cassie Air, Iridia, LyGenesis, Morphoceuticals, and an observer at Volt. Justin previously served on the Boards of Gilgamesh (acquired, AbbVie), Elevian, Dimension Inx, Zafrens, and Iviva Medical (acquired, United Tx).Over the last 20 years Justin has developed advanced technologies and companies around them for the life science and deep tech industries. Justin has developed new medicines and medical devices from the bench through phase 2 clinical trials in various diseases areas with small molecules, antibodies, oligos and vectored vaccines across ten regulatory jurisdictions across four continents. Justin has been involved as a founder, investor, advisor or team member for more than a dozen biotech, nanotech and software companies. Prior to PML, Justin invested as founding partner at TomorrowScale Ventures, a seed-stage venture firm. Before that, Justin served as a Venture Partner at Deep Science Ventures, a venture laboratory building optimal scientific ventures from scratch based in London, UK. Justin supported their portfolio of leading early-stage deep tech startups founded through the DSV program and located throughout the world.As an operator Justin helped build and oversee the portfolio of novel antibody therapeutics designed in silico and de novo (from scratch) against difficult targets by the brilliant team at Antiverse. Prior to Antiverse, Justin served as Senior Director of Drug Development at Tetherex Pharma (now Moat Bio). Tetherex is a clinical-stage biopharma company developing novel biologics for the treatment of inflammatory, oncologic, and infectious diseases.In his early career, Justin served as VP of Business Development and Operations at Accele BioPharma and Associate at Accele Venture Partners, a biotech accelerator and VC fund. Justin also founded SnapLab Technologies (lab automation and machine vision for oil and gas surface analysis) and productivity software company Chorus Labs (acquired 2015; Creators of Baton, email+kanban+chat).

Experience

1. Board Observer

   Volt

   Aug 2025 — Present · Tulsa, OK, US

Education

• Oklahoma City University

  MBA, Business Administration

  2009 — 2010

• University of Oklahoma

  Bachelor of Science (B.Sc.), Biomedical Sciences, Zoology, Business

  2005 — 2007

Skills

• Licensing
• Commercialization
• Strategic Alliances
• Venture Capital
• Finance
• Medical Devices
• Clinical Research
• Biotechnology
• Corporate Development
• Pharmaceutical Industry
• Software Development
• Clinical Development
• Business Modeling
• Strategic Consulting
• Clinical Trials
• Strategic Planning
• Biochemistry
• Management
• Drug Discovery
• Drug Development
• Biopharmaceuticals
• Executive Management
• Business Planning
• Strategic Partnerships
• Life Sciences
• Product Development
• Technology Transfer
• Immunology
• Market Analysis
• Data Analysis
• Science
• Research
• Market Research
• Competitive Analysis
• Start-Ups
• Strategy
• Competitive Intelligence
• Consulting
• Mergers & Acquisitions
• Entrepreneurship